Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Defence Therapeutics Appoints Dr. Amie Phinney As Chief Executive Officer

PRIVATEAug 04, 2026•5 days ago

Position

Chief Executive Officer

Company

Defence Therapeutics

Dr. Amie Phinney
VancouverBiotechnologyHealth CareTherapeutics

Description

Defence Therapeutics has appointed Dr. Amie Phinney as the President and Chief Executive Officer, effective August 1, 2026. This leadership transition marks a significant step for the company as it continues to advance its strategic goals.

Company Information

Company

Defence Therapeutics

Location

Vancouver, British Columbia, Canada

About

Defence Therapeutics is a publicly-traded clinical-stage biotechnology company working on engineering the next generation vaccines and ADC products using its proprietary platform. The core of Defence Therapeutics platform is the ACCUM® technology, which enables precision delivery of vaccine antigens or ADCs inside target cells and favoring their processing and activities. As a result, increased efficacy and potency can be reached against catastrophic illness such as cancer and infectious diseases.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Defence Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.